2019 National TB Conference Cyber Poster Session
Modalities to determine medication adherence: DOT, VDOT, WDOT
16. A randomized trial of in-person versus electronic directly observed therapy (DOT) for tuberculosis treatment
Authors: Joan Mangan, Michelle Macaraig, Kin Chee Lam, Marco Salerno, Neela Goswami, Sarah J. Kiskadden-Bechtel, Michael Reaves, Andrew Hill, Neil Schluger, Andrew Vernon
17. Challenges across four types of directly observed therapy
Authors: Joan Mangan, Kin Chee Lam, Sarah J. Kiskadden-Bechtel, Marco Salerno, Michael Reaves, Michelle Macaraig, Christine Chuck, Neela Goswami, Andrew Hill, Andrew Vernon, Joseph Burzynski
18. Utilizing Data to Establish an Evidence-based Statewide Asynchronous Video Directly Observed Therapy Program
Authors: Nancy Baruch, Cherie Helfrich, Dorothy Freeman, Katrina C. Rios
19. Mobile Technology Innovation in the US Pacific Islands: Guam’s Use of Asynchronous Video Directly Observed Therapy for Tuberculosis
Authors: Katrina Rios, Josephine T. O’Mallan, Chima Mbakwem, Jenette S. Florig, Larissa W. Camacho
20. What are the potential savings of electronic directly observed therapy for health departments? Evidence from an economic evaluation in New York City, Rhode Island, and San Francisco
Authors: Garrett Asay,Kin Chee Lam, Joan Mangan, Laura Romo, Caroline Gummo, Kristen St. John, Michelle Macaraig, Joseph Burzynski, Suzanne M. Marks, Chris Keh, Sapna Morris
21. Using Self-Administered Rifapentine and Isoniazid (INH) 12-Dose Regimen to Treat Latent Tuberculosis Infection (LTBI)
Authors: Patty Woods, Alfred Lardizabal
22. Bringing Screening and Treatment for Latent TB Infection into Mainstream Primary Medical Care: Implementation at a Family Medicine Clinic in Santa Ana, CA
Authors: Emily Tomich, Emily Dow, Manisha Ati, Ruby Gonzalez, Sanghyuk Shin, Tessa Mochizuki, Shereen Katrak, Michael Carson, Julie Low, Lauri D Thrupp
23. Patient time and costs associated with directly observed therapy: Evidence from New York City, Rhode Island, and San Francisco
Authors: Garrett Asay, Kin Chee Lam, Joan Mangan, Laura Romo, Caroline Gummo, Kristen St. John, Michelle Macaraig, Joseph Burzynski, Suzanne M. Marks, Chris Keh, Sapna Morris
24. Comparing electronic directly observed therapy (DOT) to in-person DOT: Patients’ perspectives
Authors: Joan Mangan, Marco Salerno, Michael Reaves, Kin Chee Lam, Michelle Macaraig, Joseph Burzynski, Sarah J. Kiskadden-Bechtel, Neela Goswami, Andrew Hill, Andrew Vernon
25. Expeditious Completion: VDOT vs. DOT for Harris County Public Health Patients with TB infection
Authors: April Beeks, Genevieve Sanders, Mary Scott, Les Becker, Umair Shah,
